BEIJING--(BUSINESS WIRE)--China Medical Technologies, Inc. (the “Company”) (NASDAQ: CMED), a leading China-based medical device company that develops, manufactures and markets high intensity focused ultrasound products and advanced in-vitro diagnostic systems, today announced that it has successfully completed the development of two Down syndrome diagnostic reagents that use chemiluminescence immunoassay technology. The Company is expected to introduce these two new reagents in early 2007, bringing the Company’s total kit offering to 58 from 56.
